REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,492,130 | +115.2% | 34,250 | +91.9% | 0.14% | +121.0% |
| Q1 2023 | $1,622,922 | -70.0% | 17,850 | -53.3% | 0.06% | -64.8% |
| Q2 2021 | $5,409,000 | +42.0% | 38,219 | 0.0% | 0.18% | +34.4% |
| Q1 2021 | $3,810,000 | -19.4% | 38,219 | 0.0% | 0.13% | -21.1% |
| Q4 2020 | $4,725,000 | -36.6% | 38,219 | -50.0% | 0.17% | -40.5% |
| Q3 2020 | $7,447,000 | -6.2% | 76,440 | +50.2% | 0.28% | -7.6% |
| Q2 2020 | $7,943,000 | +56.6% | 50,907 | +44.9% | 0.30% | +31.9% |
| Q1 2020 | $5,071,000 | -6.1% | 35,129 | +33.0% | 0.23% | +12.3% |
| Q4 2019 | $5,399,000 | – | 26,412 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |